Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BSXthis companyBoston Scientific Corporation	$43.91	48.65×	5.82×	7.03×	29.7×	100.4%	69.0%	19.8%	14.4%	11.9%	8.8%	2.6%	0.51×	2.03×	11.38×	1.62×	0.0%	6	2.89	2	C+
ANGOAngioDynamics, Inc.	$12.00	-12.4×	2.65×	1.42×	818×	-138.7%	54.6%	-12.5%	-11.5%	-21.5%	-20.7%	0.1%	0×	-110.38×	-133.54×	2.19×	0.0%	5	2.38	2	C+
ATRCAtriCure, Inc.	$57.63	-164.83×	3.84×	3.53×	111.39×	-104.6%	74.4%	-0.6%	-2.1%	-2.3%	-0.6%	2.6%	0.18×	-4.89×	-0.59×	3.96×	0.0%	8	11.96	3	B-
CNMDCONMED Corporation	$51.69	26.71×	1.22×	0.92×	11.64×	119.6%	52.8%	10.3%	3.4%	4.6%	4.6%	12.0%	0.81×	4.5×	4.54×	2.14×	2.0%	8	1.96	3	B+
CVRXCVRx, Inc.	$0.77	-3.48×	4.71×	3.27×	-3.43×	-11723.2%	85.3%	-90.5%	-94.1%	-135.6%	-56.0%	-22.0%	1.29×	0.53×	-8.8×	7.63×	0.0%	3	-9.03	1	D+
EWEdwards Lifesciences Corporation	$103.97	46.33×	4.82×	8.22×	33.31×	-37.2%	78.1%	27.0%	17.7%	10.4%	11.4%	2.7%	0.07×	-1.56×	0×	3.72×	0.0%	6	12.89	3	B
Peer median	—	-3.48×	3.84×	3.27×	33.31×	-104.6%	74.4%	-0.6%	-2.1%	-2.3%	-0.6%	2.6%	0.18×	-1.56×	-0.59×	3.72×	0.0%	6	2.38	3	—